Press "Enter" to skip to content

India’s second COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech’s Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got nod from the Drugs Controller General of India (DCGI) on Thursday for human clinical trials.

Leave your comments

%d bloggers like this: